Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
109 hedge funds and large institutions have $221M invested in Immunomedics Inc in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 19 reducing their positions, and 12 closing their positions.
221% more call options, than puts
Call options by funds: $13.4M | Put options by funds: $4.17M
142% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 19
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
32% more capital invested
Capital invested by funds: $167M → $221M (+$53.5M)
8% more funds holding
Funds holding: 101 → 109 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$9.87M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$5.68M |
| 3 |
Millennium Management
New York
|
+$4.6M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.46M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$3.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.1M |
| 2 |
NC
Nexthera Capital
New York
|
-$4.11M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.9M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$2.81M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.75M |
IMMU Hedge Fund Activity: Q4 2016 in Review
109 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2016, worth a combined $221M — up 32% from $167M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IMMU positions and 12 closed out — a net gain of 8 holders — while 46 added to existing stakes and 19 trimmed.
The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $9.87M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $5.1M sold.
- 109 institutional investors held Immunomedics Inc (IMMU) as of Q4 2016, up from 101 in Q3 2016.
- Funds reported $221M of Immunomedics Inc stock for Q4 2016, up 32% quarter-over-quarter.
- 20 funds opened new Immunomedics Inc positions in Q4 2016 and 12 closed out, a net change of +8 holders.
- The largest Immunomedics Inc buyer in Q4 2016 was EverPoint Asset Management, an estimated $9.87M added.
- The largest Immunomedics Inc seller in Q4 2016 was Balyasny Asset Management, an estimated $5.1M sold.
Based on aggregated 13F filings for Q4 2016.